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Mitochondrial dysfunction and loss of glutamate
uptake in primary astrocytes exposed to titanium
dioxide nanoparticles†
Christina L. Wilson,a Vaishaali Natarajan,a Stephen L. Hayward,a Oleh Khalimonchukb
and Srivatsan Kidambi*a,c,d
Titanium dioxide (TiO2) nanoparticles are currently the second most produced engineered nanomaterial
in the world with vast usage in consumer products leading to recurrent human exposure. Animal studies
indicate signiﬁcant nanoparticle accumulation in the brain while cellular toxicity studies demonstrate
negative eﬀects on neuronal cell viability and function. However, the toxicological eﬀects of nanoparticles
on astrocytes, the most abundant cells in the brain, have not been extensively investigated. Therefore, we
determined the sub-toxic eﬀect of three diﬀerent TiO2 nanoparticles (rutile, anatase and commercially
available P25 TiO2 nanoparticles) on primary rat cortical astrocytes. We evaluated some events related to
astrocyte functions and mitochondrial dysregulation: (1) glutamate uptake; (2) redox signaling mechanisms by measuring ROS production; (3) the expression patterns of dynamin-related proteins (DRPs) and
mitofusins 1 and 2, whose expression is central to mitochondrial dynamics; and (4) mitochondrial morphology by MitoTracker® Red CMXRos staining. Anatase, rutile and P25 were found to have LC50 values
of 88.22 ± 10.56 ppm, 136.0 ± 31.73 ppm and 62.37 ± 9.06 ppm respectively indicating nanoparticle
speciﬁc toxicity. All three TiO2 nanoparticles induced a signiﬁcant loss in glutamate uptake indicative of a
loss in vital astrocyte function. TiO2 nanoparticles also induced an increase in reactive oxygen species
generation, and a decrease in mitochondrial membrane potential, suggesting mitochondrial damage.
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1.

TiO2 nanoparticle exposure altered expression patterns of DRPs at low concentrations (25 ppm) and
apoptotic ﬁssion at high concentrations (100 ppm). TiO2 nanoparticle exposure also resulted in changes
to mitochondrial morphology conﬁrmed by mitochondrial staining. Collectively, our data provide compelling evidence that TiO2 nanoparticle exposure has potential implications in astrocyte-mediated neurological dysfunction.

Introduction

Titanium dioxide (TiO2) nanoparticles are the second most
produced engineered nanomaterial in the world with a vast
majority utilized in cosmetics, including sunscreens, and
other consumer products.1,2 The unique properties of TiO2
nanoparticles have also proven useful in applications of air
and water purification and energy storage providing increased
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opportunities for commercial and industrial exposure to these
nanoparticles.3 This increased human and environmental
exposure to TiO2 nanoparticles has led to an intense scrutiny
of its biocompatibility resulting in many animal and in vitro
studies that suggests a need for concern.4–6 Wang and coworkers demonstrated that a single oral administration of TiO2
nanoparticles in rats caused nanoparticle distribution and
accumulation in various tissues including the brain.7 Intranasal exposure of TiO2 nanoparticles also demonstrated high
accumulation of the nanoparticles in diﬀerent regions of the
brain resulting in increase of glial fibrillary acidic protein
(GFAP) positive cells, oxidative stress, and brain tissue
damage.8 Wu and co-workers exposed TiO2 nanoparticles to
PC12 cell lines and observed decreased cell viability, generation of reactive oxygen species (ROS), loss of mitochondrial
membrane potential (MMP) and increased expression of biomarkers associated with apoptosis per cell death.9 Long et al.
demonstrated a cell-dependent eﬀect due to exposure to TiO2
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nanoparticles wherein BV2 microglia cell lines had a faster
decrease in viability compared to N27 neuronal cell lines
suggesting that microglia are more susceptible to TiO2 nanoparticles.10 Together, these in vitro and in vivo studies indicate
that exposure to TiO2 nanoparticles result in a certain
degree of nanoparticle accumulation and toxicity. However,
the majority of these studies have focused on neurons and
neuronal cell lines leaving a significant gap of knowledge
regarding toxicity mechanisms in other brain cells including
astrocytes.
Astrocytes are the most abundant cell type in the brain;
they are intimately associated with synapses and govern key
steps in synapse formation and plasticity. Glutamate homeostasis is maintained by neuron–astrocyte interaction via several
glutamate transporters and is a key metabolic function of
astrocytes and neurons at the mitochondrial level.11–14 Numerous studies have revealed that astrocytes release neuroactive
substances, called gliotransmitters, including glutamate,
GABA, ATP/adenosine, or D-serine.15–19 These gliotransmitters
activate receptors in neurons, exerting diverse and complex cellular eﬀects that result in the regulation of the neuronal excitability, synaptic transmission and plasticity, and neural
network function. The increasing interest in identification of
astrocytes’ roles in regulating brain function has led to great
excitement regarding their potential impact on prospective
therapeutics for neurological conditions. Hence, astrocytes
might possess the key to understand the underlying mechanisms that mediate brain injury due to exposure to TiO2 nanoparticles. Furthermore, all the vital roles of astrocytes in brain
function are largely energy dependent and recent reports have
indicated that high doses of TiO2 nanoparticles induce significant mitochondrial injury and alter the bioenergetic function
of mitochondria.20,21 Thus, it is critical to understand the
mechanisms of toxicity in astrocytes, especially in regard to
mitochondrial health.
Mitochondria are essential bioenergetic organelles that
exploit a highly dynamic nature to participate in several processes vital to meet the energy requirements of the cell. The
constant balance of merging (fusion) and dividing (fission)
maintains the mitochondrial dynamics facilitating cell bioenergetic demands and eliminating injured mitochondria
thereby assuring suﬃcient energy supply for proper cell function. Fusion, mediated by membrane-anchored dynamin
family members mitofusins (Mfn 1 and 2), is required for
mitochondrial (mt) DNA maintenance because it allows
mtDNA exchange and protects the mtDNA from damage
during stress.22,23 Fission, mediated by cytosolic dynamin
family member dynamin-related protein 1 (Drp1), is essential
for mitochondrial distribution and selective elimination of
damaged mtDNA. Mitochondria utilize fission in response to
extensive and persistent mitochondrial damage, as abundant
fission can result in the release of factors to initiate the
cascade for cellular apoptosis.24 The endocytosis and interaction with mitochondria of TiO2 nanoparticles have been confirmed by previous studies, however these studies have not
ventured into mechanisms of toxicity beyond ROS generation,
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anti-oxidant response and MMP disruption leaving a gap in
the current toxicity knowledge base.25,26
In this study we sought to assess the impact of low concentrations of TiO2 nanoparticles on cellular activity of primary
cortical astrocytes. We utilized three commercially employed
TiO2 nanoparticles (P25, anatase, and rutile), to investigate
nanoparticle specific perturbation in an explicit range of concentrations mimicking TiO2 nanoparticle accumulation.
Additionally, we evaluated the eﬀect of TiO2 nanoparticle
exposure on mitochondrial health and ROS production, indicators of perturbations in normal brain function. Our findings
demonstrate toxic eﬀects of TiO2 nanoparticles on cellular and
mitochondrial function in primary astrocytes and suggest that
mitochondrial stress can be used as an early and potent diagnostic marker for nanotoxicological inquiries.

2. Results and discussion
2.1.

TiO2 nanoparticle characterization

In this study, we utilized three diﬀerent TiO2 nanoparticles
(P25, anatase and rutile), due to their unique crystal structures
and abundance in commercial products, and performed extensive nanoparticle characterization using transmission electron
microscopy (TEM) and dynamic light scattering (DLS). TiO2
nanoparticle characterization is a vital part of understanding
and interpreting the toxic potential of nanoparticles. Furthermore, nanoparticle size and crystalline structure have been
studied as underlying characteristics for nanoparticle
toxicity.27–30 TEM images demonstrated that anatase TiO2
nanoparticles had a characteristic spherical crystal structure
while rutile nanoparticles had a typical rod-like crystal structure (Fig. 1). The anatase and rutile TiO2 nanoparticles utilized
for this study were both reported to be 50 nm in diameter by
the manufacturer, thus allowing for observations of crystal
structure influence on nanoparticle toxicity independent of
the particle size. This was important as many studies comparing pure phase rutile and anatase nanoparticles utilize
diﬀerent sized nanoparticles thus not eliminating the eﬀect of
the nanoparticle size on toxicity. The commercially used P25
nanoparticles were the third variation of TiO2 nanoparticles
that contained a 3 : 1 mixture of anatase and rutile, have structural characteristics of both anatase and rutile and were
reported to be 21 nm in diameter.
We further performed DLS and zeta potential analysis to
investigate the behavior of the particles in media used for culturing astrocytes. Previous reports have shown that nanoparticles agglomerate in cell culture media.30–33 To compare
the level of agglomeration of the TiO2 nanoparticles under
physiologically relevant conditions, in the presence of proteins
and divalent ions, we studied the agglomeration of the TiO2
nanoparticles in serum containing astrocyte culture media.
Nanoparticle suspensions were prepared in astrocytes media
in the same manner as for the cell culture studies. The nanoparticle suspensions were then characterized using DLS for
hydrodynamic diameter of the aggregates and zeta potential to
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Physical characterization of TiO2 nanoparticles. TEM images of anatase (A), P25 (B), and rutile (C). Scale bar = 100 nm.

discern nanoparticle charge and colloidal stability. As shown
in Table 1, P25, anatase, and rutile nanoparticles aggregated to
an average diameter of approximately 360 nm, 540 nm, and
360 nm, respectively. We observed that the average hydrodynamic diameter had crystalline form dependence, but not a
concentration dependence indicating that the relative concentrations would be reliable for our study. The type of crystal structure of the particles (anatase vs. rutile) and the relative
composition of the three forms of nanoparticles might attribute
to the observed variations in their aggregation size considering
varied interaction with media components.34 Zeta potential was
also measured for the three TiO2 nanoparticles (Table 1). The
zeta potential values did not significantly change in the three
forms of the nanoparticles and in all three concentrations. In
all cases the weakly negative net charge of the nanoparticles
highlighted their inherent colloidal instability driven by favorable aggregation forces. Our extensive characterization provides
us with valuable information about the intricate characteristics
of the nanoparticles, including size, charge and driving forces
for aggregation, that elicits valuable insight for data analysis
and comparison with previous studies.

Table 1 Physical characterization of TiO2 nanoparticles. Hydrodynamic
diameter and zeta potential measured in culture media. Data are
expressed as the mean ± standard deviation of two independent
samples

Astrocyte culture mediaa

Size
Nanoparticle

(nm)

ppm

Hydrodynamic
diameter (nm)

Zeta potential
(mV)

P25 (70%
anatase & 30% rutile)

∼21

Rutile

∼50

Anatase

∼50

25
50
100
25
50
100
25
50
100

374.3 ± 26.4
367.6 ± 15.3
337.9 ± 14.7
366.9 ± 15.0
363.5 ± 19.2
362.4 ± 18.4
541.2 ± 51.0
555.9 ± 41.3
545.3 ± 47.8

−10.7 ± 4.6
−8.5 ± 4.9
−9.2 ± 4.3
−11.4 ± 6.2
−12.1 ± 3.6
−8.1 ± 3.4
−10.4 ± 5.0
−9.4 ± 4.1
−10.8 ± 3.2

a

Composition includes 10% heat inactivated horse serum, 1% 1 M
hepes buﬀer, 1% L-glutamine, and 1% penicillin–streptomycin in
DMEM.

This journal is © The Royal Society of Chemistry 2015

2.2.

TiO2 nanoparticles cytotoxicity to primary astrocytes

We determined the concentrations of acute toxicity to primary
rat cortical astrocytes using lethal concentration assay by
exposing primary astrocytes to diﬀerent concentrations of the
three TiO2 nanoparticles for 24 h. As seen in Table 2 and ESI
Fig. 1,† the LC50 values of P25, anatase and rutile TiO2 nanoparticles were 62.37 ± 9.06 ppm, 88.22 ± 10.56 ppm, and 136.0
± 31.73 ppm, respectively. Our results are in agreement with
other studies indicating that the anatase crystalline phase is
more toxic than rutile.9 This result provided us with a concentration range of acute toxicity to investigate the underlying
mechanistic perturbation induced by the gradual accumulation of nanoparticles in brain observed akin to animal
models.7,8,35 Therefore, all subsequent mechanistic studies
were carried out using three diﬀerent concentrations of TiO2
nanoparticles (25 ppm, 50 ppm, and 100 ppm) with 24 h
exposure that is reflective of the LC50 data. These concentrations are in the relevant sub-acute toxicity range, as compared to previous studies that have been carried out using
higher concentrations and were thus unable to discern
mechanistic response beyond loss of viability.36,37 Two recent
studies have employed lower concentrations to delineate the
toxicity mechanisms on brain cells, however these studies are
limited as they use cell lines and lack understanding with
regard to the TiO2 eﬀect on mitochondria.9,38 Cell lines are
commonly utilized in toxicity studies due to ease of culture
and stability of phenotype over multiple passages, however,

Table 2 Lethal concentration summary table. Lethal concentration was
quantiﬁed at 0 ppm, 25 ppm, 50 ppm, 100 ppm, 300 ppm, 500 ppm,
700 ppm, and 1000 ppm nanoparticle (ESI Fig. 1). P25 was observed to
be the most lethal nanoparticle after 24 h treatment followed by anatase
and rutile as determined by calculating the LC50 utilizing sigma plot analysis. N = 6

Nanoparticle

LC50 value (ppm)

P25
Anatase
Rutile

62.37 ± 9.06
88.22 ± 10.56
136.0 ± 31.73
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the immortalization process often causes physiological diﬀerences when compared to cells in vivo.39 In our study, we utilized
primary astrocytes isolated from the rat brain, which are generally recognized as a better in vivo mimic of the cells. These
studies provide basis for the TiO2 nanoparticle toxic eﬀect,
however, the eﬀect of TiO2 nanoparticles on mitochondria, and
essential bioenergetic organelles, is largely unexplored. Therefore, the main goal of our study is to further probe the eﬀect of

Nanoscale

TiO2 nanoparticle on primary astrocytes focusing on the
changes in mitochondrial dynamics and function.
2.3.

TiO2 nanoparticle and astrocytes viability

To study the eﬀect of TiO2 nanoparticles on the primary astrocyte morphology and viability, we utilized phase images and
the MTT assay (Fig. 2). Changes in the astrocyte morphology
represent a strong qualitative indicator and the MTT assay is a

Fig. 2 Eﬀect of TiO2 nanoparticles on morphology and viability of astrocytes. A concentration- and form-dependent loss in morphology and viability was observed by phase images (A) and MTT assay (B) after 24 h exposure. P25 and anatase 100 ppm treated astrocytes exhibited the greatest loss
(65% and 61% decrease, respectively) in viability and exposure to rutile 100 ppm TiO2 nanoparticles resulted in a lesser decrease (37%). In all three
nanoparticles, cells treated with 25 ppm and 50 ppm show much less change in morphology than 100 ppm. Scale bar = 200 μm. N = 6, “*” indicates
P < 0.05.
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This journal is © The Royal Society of Chemistry 2015

View Article Online

Nanoscale

standard indicator of cellular injury and viability loss.26 We
observed concentration- and phase-dependent changes in morphology and viability of astrocytes in the presence of TiO2
nanoparticles after 24 h exposure (Fig. 2A). Exposure to
100 ppm of P25 and anatase demonstrated the most profound
changes in cell morphology and viability (65% and 61% loss of
viability respectively), as compared to 100 ppm rutile (37%). In
addition, the change in morphology, and subsequent cell viability, was concentration dependent and correlated well with
the LC50 values with the greatest diﬀerence in P25, anatase
and rutile at each concentration (Fig. 2B). Exposure to 50 ppm
resulted in 50%, 39% and 34% viability loss in P25, anatase
and rutile nanoparticles, respectively. Finally exposure to
25 ppm resulted in the least damage to viability with only
28%, 27% and 16% viability loss in P25, anatase and rutile,
respectively. Similar results have been found in other cell lines
and mixed cultures that observed reduced cell size and
rounded shape prior to cell detachment.25,26 Overall, these
experiments provide strong evidence that we were working
across the sub-acute toxicity range with the highest concentration of nanoparticle (100 ppm) exposure in the most lethal
nanoparticles causing 65% and the lowest concentration
(25 ppm) causing 28% viability loss in primary astrocytes.
2.4. TiO2 nanoparticle exposure induces loss in glutamate
uptake
To study the eﬀect of TiO2 nanoparticle exposure on primary
astrocyte function, we measured glutamate uptake (Fig. 3).
Astrocytes are the major cells of the brain to clear and process
glutamate for future neuron function and prevention of neural
excitotoxicity, therefore a loss of this function indicates
damage to astrocytes and could have a negative eﬀect on the
overall brain health.40,41 We observed significant concentration
(25 ppm, 50 ppm, and 100 ppm) and type dependent (P25,
anatase, and rutile) loss in glutamate uptake in astrocytes due

Paper

to exposure to TiO2 nanoparticles. The exposure of astrocytes
to 25 ppm, 50 ppm, and 100 ppm of P25 resulted in 31%, 33%
and 27% reduction in glutamate uptake, respectively. The
exposure of astrocytes to 50 ppm and 100 ppm of anatase
resulted in 45% and 46% reduction in glutamate uptake,
respectively, while 25 ppm did not aﬀect the glutamate uptake
in astrocytes compared to untreated cells. The exposure of
astrocytes to rutile resulted in a negligible reduction in glutamate uptake in 25 ppm and 50 ppm while 100 ppm resulted in
40% reduction in glutamate uptake. These data indicate that
TiO2 nanoparticle exposure exerts both concentration- and
type-dependent eﬀects on glutamate uptake of astrocytes with
P25 causing the highest damage to astrocyte function even at a
low concentration of 25 ppm.
The ability to produce, uptake and recycle glutamate is a
vital role of astrocytes in the brain as they interact with
neurons for healthy brain functions.40,41 Hence, the compromise of this function through TiO2 nanoparticle exposure is
indicative of a potentially detrimental eﬀect to brain function
and an increased risk toward the neurodegenerative process.
Ze and coworkers observed significant glial proliferation,
increase in glutamate content, and decrease in glutamate
synthetase, a key enzyme for glutamate recycling, in mice
treated for 9 months with low concentration TiO2 nanoparticles.42 This work provided evidence that TiO2 nanoparticles have a direct eﬀect in TiO2 neurotoxicity through the
inhibition of glutamate metabolism. However, with the complexity of the animal model it is not known if glutamate
metabolism of astrocytes is hindered which could contribute
to disruption of glutamate metabolism. We suspect that the
observed in vivo failure of glutamate metabolism is due to the
TiO2 nanoparticle exposure that was related to the disruption
in the glutamate uptake of astrocytes as demonstrated in our
current study wherein we observe a significant loss in glutamate uptake specifically in astrocyte cultures in the presence
of TiO2 nanoparticles. Combining these studies provide strong
evidence to indicate that further understanding of the mechanisms leading to a loss of glutamate metabolism needs to be
explored due to the potential for neurodegenerative eﬀects in
the brain.
2.5. Increased reactive oxygen species and mitochondrial
dysfunction induced by TiO2 nanoparticles

Fig. 3 Eﬀect of TiO2 nanoparticles on glutamate uptake. TiO2 nanoparticle exposure resulted in decrease of glutamate uptake observed
indicating loss of important cellular functions in astrocytes. N = 3,
“*” indicates P < 0.05.

This journal is © The Royal Society of Chemistry 2015

To further investigate the damage caused by TiO2 nanoparticle
exposure in primary astrocytes, we determined intracellular
levels of ROS when exposed to TiO2 nanoparticles for 24 h.
ROS generation has previously been observed to accompany a
loss of glutamate uptake linking induced mitochondrial stress
to loss of astrocyte function and could therefore be an attribute of TiO2 nanoparticle toxicity.43–45 Also, several studies
have demonstrated that TiO2 nanoparticles induce ROS
species often leading to programmed cell death.29,38 We
observed a concentration- and type-dependent increase in ROS
production (as indicated by enhanced CM-H2DCFDA fluorescence) upon the exposure of primary astrocytes to TiO2
nanoparticles (Fig. 4A). The exposure of astrocytes to 100 ppm
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and concentration dependent mitochondrial stress leading to
loss of mitochondrial health and function.
2.6. TiO2 nanoparticle induced alteration in mitochondrial
morphology

Fig. 4 Mitochondrial dysfunction. ROS generation (A) and decrease in
MMP (B) indicate loss of mitochondrial health due to nanoparticle stress.
N = 5, “*” indicates P < 0.05.

of P25 and anatase resulted in 1.9 ± 0.7 and 1.8 ± 0.4 fold
increase in ROS production while exposure of 100 ppm of
rutile did not lead to a significant ROS production, as compared to untreated cells. The higher production of ROS in P25
and anatase indicate that primary astrocytes are in a high
stress environment.46 This observation is comparable to other
studies that have demonstrated a similar eﬀect of TiO2 nanoparticle exposure on alteration of oxidative status in both
animal and cell models.38,47
Elevated intracellular ROS is an accepted early sign of
altered mitochondrial function and can often lead to a state of
mitochondrial dysfunction that has been indicated in early
stages of cell death.48 We thus investigated the eﬀect of TiO2
nanoparticle exposure on MMP (Fig. 4B) assessing the
depolarization of mitochondrial membrane, an important
marker of mitochondrial health.26,49 We observed a 25%, 22%
and 30% decrease in MMP in astrocytes exposed to P25 in
25 ppm, 50 ppm and 100 ppm, respectively, while only
100 ppm of anatase demonstrated 24% loss in MMP. Interestingly, rutile did not have a significant eﬀect on the MMP even
when exposed to 100 ppm concentration. From this data, we
observed that exposure to TiO2 nanoparticles results in type

18482 | Nanoscale, 2015, 7, 18477–18488

Imbalances in mitochondrial dynamics are known to impede
cellular bioenergetics and contribute to numerous neurodegenerative diseases.50 To investigate the eﬀect of nanoparticle treatment on mitochondrial dynamics, we measured
the relative gene expressions of Mfn1, Mfn2, and Drp1,
markers associated with mitochondrial fusion and fission
events (Fig. 5). The LC50 of P25, anatase and rutile TiO2 nanoparticles are 62.37 ppm, 88.22 ppm, and 136.0 ppm, respectively. Therefore, to probe the mechanistic understanding of
the changes in mitochondrial dynamics, we carried out
studies here on using only 25 ppm and 100 ppm to demonstrate the drastic diﬀerences in the changes in mitochondria.
We postulate that low sub-toxic concentrations (25 ppm) will
cause stress resistant networks and high toxic concentrations
(100 ppm) will cause mitochondrial fragmentation. 50 ppm
was not utilized as this value was close to the LC50 value for
both P25 and anatase nanoparticles which would not allow for
validation of our hypothesis. Mfn1 and Mfn2 are essential proteins for the fusion process while Drp1 is an essential protein
for the fission process. Changes in transcript levels of Mfn1
and Mfn2 have been reported to correlate with changes in
mitochondrial dynamics.51 Therefore we quantified the relative
transcript levels in astrocytes treated with low concentration
(25 ppm) and high concentration (100 ppm) to predict if astrocytes experience a perturbation in mitochondrial dynamics
after 24 h treatment. Post treatment with 25 ppm of P25, we
observed a 1.6 ± 0.1 and 1.5 ± 0.1 fold up-regulation of Mfn1
and Mfn2 transcripts, respectively, while no significant change
in Drp1 was observed indicative of increased mitochondrial
tubulation. Astrocytes treated with 25 ppm anatase and rutile
also did not experience a significant increase in Drp1 (1.1 ± 0.1
and 1.2 ± 0.1, respectively) but astrocytes treated with 25 ppm
anatase nanoparticles showed a significant increase in Mfn1
(1.5 ± 0.1) but not Mfn2 (1.2 ± 0.1) and astrocytes treated with
25 ppm rutile nanoparticles observed a significant increase in
Mfn2 (1.5 ± 0.1) but not Mfn1 (1.3 ± 0.2). Although both Mfn1
and Mfn2 are similarly involved in the mitochondrial fusion
process studies have shown that they perform unique roles
and therefore the diﬀerence of upregulation observed between
these treatments may explain a diﬀerence observed in mitochondrial morphology.52 Furthermore, Tondera et al. observed
that Mfn1 significantly contributed to mitochondrial tubulation while Mfn2 did not play a specific role and therefore we
suspect that the mitochondria of astrocytes treated with
25 ppm anatase nanoparticles may be experiencing a higher
degree of tubulation than those treated with 25 ppm rutile
nanoparticles.23 Astrocyte exposed to 100 ppm of P25, anatase,
and rutile nanoparticles experienced significant increases in
both mitofusin genes but, contrary to their 25 ppm treated
counter parts, Drp1 was significantly up-regulated (2.1 ± 0.1
fold, 1.5 ± 0.1 fold and 1.6 ± 0.1 fold, respectively) which could
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Fig. 5 Mitochondrial dynamics perturbation. Increase in Mfn1, Mfn2
and Drp1 indicate a deviation from normal mitochondrial dynamic
balance toward hyperfusion in 25 ppm and 50 ppm treated cells and
ﬁssion in 100 ppm treated cells. N = 3, “*” indicates P < 0.05.

indicate the activation of the fission process leading to mitochondrial fragmentation and cell death.
We further confirmed the change in dynamics by observing
mitochondrial morphology utilizing confocal images (Fig. 6).
The mitochondrial morphology was observed to alter in a
nanoparticle and concentration dependent manner. Untreated
astrocytes and 25 ppm rutile were observed to maintain
similar morphology while 100 ppm rutile, 25 ppm anatase,
and 25 ppm P25 treated astrocytes appear in various stages of
hyperfusion. 25 ppm P25 had the greatest degree of fusion
while 100 ppm rutile exhibited slight hyperfusion morphology.

This journal is © The Royal Society of Chemistry 2015
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Mitochondria of astrocytes treated with 100 ppm P25 and
anatase displayed a high degree of fragmentation. Overall the
images appear to correlate well with the gene expression,
especially in the P25 treated samples, however cells treated
with 100 ppm rutile show a significant up-regulation in
Drp1 gene expression and yet appear to maintain a slightly
hyperfused mitochondria. This may reflect on the potential of
gene expression as an early biomarker suggesting that a prolonged (greater than 24 h) exposure may result in fragmentation. Braydich-Stolle and co-workers used a similar strategy to
demonstrate the localization and causative damage of the
mitochondria due to TiO2 nanoparticle treatment on keratinocytes.58 Chen and co-workers utilized the mitotracker imaging
to demonstrate various aspects of compromises to the disruption of the mitochondrial dynamics in cells.59 Jou and coworkers have demonstrated similar mitochondrial morphology
in primary astrocytes wherein the cells had a typical rod- or
thread-like morphology without oxidative stress while oxidative
stress resulted in severe fragmentation of mitochondria.53 Our
results demonstrate similar morphology changes to the mitochondria due to exposure of the nanoparticles to primary
astrocytes. Further we performed acellular control experiments
wherein we stained 100 ppm of P25, anatase and rutile nanoparticles with mitotracker with cells present (ESI Fig. 3†). No
fluorescence was observed in these controls which demonstrated the sensitivity of the method without interference or
background from nanoparticles.
Toxicity reports have consistently observed that anatase and
commercially used P25 TiO2 nanoparticles are more toxic than
rutile TiO2 nanoparticles resulting in increased tissue damage,
oxidative stress and cell death.9 This is generally understood to
have roots in the diﬀerence of physicochemical properties
between the two crystalline structures of nanoparticles resulting in varied interactions with the cells and environmental
components.34,54,55 In this study we demonstrated that the
anatase and P25 TiO2 nanoparticles induce concentration
dependent mitochondrial dysfunction, ROS generation, and
loss of astrocytic glutamate uptake. We also observed that
rutile nanoparticles induced a substantial loss of glutamate
uptake in the highest concentration without significant mitochondrial dysfunction and ROS generation. Many more studies
have been devoted to anatase and P25 TiO2 nanoparticles;
however, the current study suggests that rutile nanoparticles
can induce loss of function without induction of typical cytotoxic markers. Therefore further examination of rutile nanoparticle interaction with cells is critical in future studies.

3. Conclusions
Overall, we observed that culture of primary astrocytes with
commercially and industrially relevant TiO2 nanoparticles
caused concentration- and type-dependent cytotoxic eﬀects in
primary astrocytes. In P25 and anatase TiO2 nanoparticle
treated astrocytes the glutamate uptake was significantly disrupted even at concentrations as low as 25 ppm. These altera-
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Fig. 6 Mitochondrial morphology observed by confocal ﬂuorescent microscopy in primary rat astrocytes using MitoTracker® Red CMXRos. Scale
bar 50 μm in full images. Magniﬁed region emphasized by a gold box. Scale bar of magniﬁed region is 12.5 μm. In the control image, long ﬁber-like
mitochondrial morphology can be observed, as compared to fragmented and swollen mitochondria as seen in nanoparticle treated samples.
Magniﬁed region emphasized by a gold box. Scale bar of magniﬁed region is 12.5 μm. Red is MitoTracker® Red CMXRos.

tions correlate with an increase in the amount of intracellular
ROS production and significant deficits in mitochondrial
activity. Finally, we demonstrated that exposure to TiO2 nanoparticles results in significant damage to mitochondrial
dynamics as seen in the up-regulation of Mfn1 and Mfn2 at
25 ppm and up-regulation of Drp1 at 100 ppm, markers
indicative of the fusion and fission processes, respectively.
These changes in mitochondrial morphology were further
confirmed with fluorescent images of mitochondria in which
100 ppm of P25 and anatase, which significantly increased
Drp1 expression, promoted fragmentation and 25 ppm of
P25 and anatase resulted in various degrees of tubulation.
This was not observed in cells treated with rutile TiO2

18484 | Nanoscale, 2015, 7, 18477–18488

nanoparticles which resulted in significant loss of
glutamate uptake without inducing significant cell stress.
From these observations, we propose that P25 and anatase
TiO2 nanoparticles induce a loss of glutamate uptake, an
important astrocyte function, while the mechanisms of
toxicity for rutile TiO2 nanoparticles remain unclear. P25 and
anatase TiO2 nanoparticles induce cytotoxicity of astrocytes by
(1) disrupting the mitochondrial dynamics, (2) inducing
damage to the mitochondrial health and (3) fostering generation of ROS (Fig. 7). Therefore, we conclude that TiO2 nanoparticles could potentially contribute to subsequent adverse
health eﬀects and the development of neurodegenerative
diseases.

This journal is © The Royal Society of Chemistry 2015
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Fig. 7 Schematic representation of our postulated mechanisms mediating TiO2 nanoparticle toxicity in astrocytes. We propose that P25 and
anatase TiO2 induces cytotoxicity and loss of functions in astrocytes through the change in intracellular oxidation state mediated by an increase of
ROS production and mitochondrial dysfunction. Mitochondrial ﬁssion and fusion cycles normally consist of ﬁssion mediated by Drp1 and fusion
mediated by Mfn1 and Mfn2. High concentration (100 ppm) of TiO2 nanoparticles induces high levels of stress and mitochondrial fragmentation via
Drp1-mediated ﬁssion. Low concentration (25 ppm) of TiO2 nanoparticles induce low stress response, which leads to mitochondrial fusion to create
stress resistant networks.

4.
4.1.

Experimental
Preparation of TiO2 nanoparticle suspensions

The nanoparticles utilized for this study were Degussa P25
[Sigma Aldrich, St. Louis, MO], anatase, or rutile [Mk Nano]
titanium dioxide nanoparticles. Prior to suspension all nanoparticles were sterilized by UV overnight. 1000 ppm stock suspensions were prepared in autoclaved 1× PBS by sonication
[FS30D Fisher Scientific] for 30 min and stored at 4 °C. For
experiments, the stock suspensions were sonicated for 30 min
in culture media.
4.2.

Isolation, seeding and treatment of primary astrocytes

This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The protocol
was approved by the Committee on the Ethics of Animal
Experiments of the University of Nebraska-Lincoln (Project ID:
1046). Primary cortical astrocytes were prepared from 1–2 dayold Sprague-Dawley rat pups of four donor rats yielding 12+
pups per litter [Charles River] in compliance with UNL’s
IACUC protocol 1046 and according to the protocol with slight
modifications.56,57 Briefly, the tissue was digested with 0.025%
Trypsin [Life Technologies] and 0.0016% DNase [Roche] which
was quenched by culture media (DMEM) [MP Biomedicals],
10% Heat Inactivated Horse Serum [PAA Lab], 1% HEPES

This journal is © The Royal Society of Chemistry 2015

[Media Tech], 1% penicillin–streptomycin [Life Technologies],
1% L-Glutamine [Life Technologies]). The inactive trypsin was
removed by centrifugation at 1700 rpm for 5 min, and the cells
were suspended in plating media and gently triturated with a
glass pipette. The cells were then passed through a 70 μm cell
filter, centrifuged, suspended in culture media and counted by
trypan blue staining with a hemocytometer. Astrocytes were
seeded on poly-L-lysine coated tissue culture plates at a density
of 500 cells per mm2. Cultures were characterized by fluorescent microscopy using anti-glial fibrillary acidic protein
(GFAP) [DAKO] and 4′,6-diamidino-2-phenylindole (DAPI)
nuclear stain [Thermo Scientific] yielding cultures of >90%
GFAP positive cells (ESI Fig. 3†).
4.3.

Nanoparticle characterization

ZetaPALS [Brookhaven instrument] was utilized to determine
the nanoparticle eﬀective diameter and Zeta potential [PALS
Zeta Potential Analyzer, Smoluchowski model] at the treatment
concentrations of 25 ppm, 50 ppm and 100 ppm. Nanoparticle
solutions were prepared with culture media at pH 7.4 as outlined for experiments. All size measurements were performed
at 25 °C and at a scattering angle of 90° and analyzed via
intensity and volumetric distribution. Nanoparticles were suspended in deionized water visualized with a Hitachi H7500
Transmission Electron Microscope on carbon coated copper
grids [Ted Pella].
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Lethal concentration assay using MTT

The concentration lethal to 50% of astrocytes (LC50) was determined utilizing the MTT [3-(4,5-dimethyldiazol-2-yl)2,5 diphenyl tetrazolium bromide] [Life Technologies] assay. It is a
colorimetric assay that evaluates the mitochondrial conversion
of the MTT salt. In short, after 24 h nanoparticle exposure the
culture media was aspirated and 5 mg ml−1 MTT working solution in DMEM incubated on live cells at 37 °C for 3 h. Lysis
buﬀer (0.1 N HCl in isopropanol) was added in a 5 : 1, lysis
buﬀer to MTT solution, ratio. The absorbance values were read
at 570/630 nm in an AD340 plate reader [Beckman Coulter].
The 570/630 nm absorbance ratio values were imputed into
Sigma plot [Systat Software] and LC50 values determined utilizing regression wizard and a four parameter logistic curve.
4.5.

Phase imaging

Morphology of live cells were assessed using an Axiovert 40
CFL [Zeiss] and images taken with a Progres C3 [Jenoptik]
camera.
4.6.

Reactive oxygen species (ROS) quantification

5-(and-6)-Chloromethyl-2′,7′-dichlorodihydrofluorescein diacetate (CM-H2DCFDA) is a fluorescent indicator activated by the
presence of ROS. The culture media was aspirated and the
cells were washed with warm 1× PBS. 10 μM CM-H2DCFDA
[Life Technologies] in DMEM was added to each well and incubated at 37 °C for 30 min. Cells were washed 3× with PBS followed by fluorobrite media [Life Technologies] added to each
well. The bottom of the well was read at excitation 495 nm and
emission 529 nm with a SLFA plate reader [Biotek]. The results
were reported as a fraction of the average untreated intensity.
4.7.

Glutamate uptake assay

The uptake of [3H] glutamic acid was used to determine
change in glutamate uptake experienced by TiO2 nanoparticle
treated astrocytes. The treatment media was removed and
replaced by serum free high glucose DMEM containing 50 µM
glutamate and 18.5 kBq of [3H] glutamic acid [Perkin Elmer].
The uptake was terminated after 15 min by removal of working
solution. Cells were washed twice with ice-cold PBS lysed in
10 mM NaOH containing 0.1% Triton X-100, and 300 µl of
lysate was assayed for [3H] by liquid scintillation counting.
The protein content was assayed using the Bradford assay.
Results were reported as CPM per µg protein.
4.8.

Mitochondrial membrane potential (MMP)

MMP was determined using tetramethylrhodamine (TMRM)
[Life Technologies], a cationic red dye which accumulates in
healthy, active mitochondria marking depolarization. The
stock solution was diluted in fluorobrite DMEM to a final concentration of 20 nM, added to cells, and incubated in the dark
at room temperature for 45 min. Afterwards, the dye was
removed and cells were washed 3× with warm 1× PBS. The fluorescence was read at emission 590 nm and excitation 573 nm.
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Results are reported as the normalized intensity to the
untreated cells.
4.9.

Gene expression

Total RNA was isolated using Trizol [Life Technologies] according to the manufacturer’s instructions. The quality and quantity was determined by using a ND-1000 spectrophotometer
[NanoDrop Technologies] and reverse transcribed using an
iSciptTM cDNA synthesis kit [Bio-Rad Laboratories] according
to the manufacturer’s instructions.
Quantitative real time PCR was performed using SYBR
Green Master Mix [Applied Biosystems, Foster City, CA] in an
ep gradient S Mastercycler [Eppendorf ]. The PCR program was
set as follows: 10 min at 95 °C, 40–60 cycles of 95 °C for 15 s
followed by annealing at 60 °C for 15 s and elongation at 72 °C
for 60 s, and finally 95 °C for 15 s to end. The primers of interest obtained from Integrated NDA Technologies [Coralville, IA]
with the following sequences: GLAST (forward 5′-CTACTCACCGTCAGCGCTGT-3′
and
reverse
5′-AGCACAAATCTGGTGATGCG-3′),
Mfn1
(forward
5′TCGTGCTGGCAAAGAAGG-3′ and reverse 5′-CGATCAAGTTCCGGGTTCC-3′),
Mfn2
(forward
5′-CGATGTGGTAGTGAGGTTGG-3′
and
reverse
5′CTCCCATCTTCCACCATTCC-3′),
Drp1
(forward
5′GAACTACCTTCCGCTGTATCG-3′
and
reverse
5′CGACCACCATCTCCAATTCC-3′). GAPDH (forward 5′-ATG ATT
CTA CCC ACG GCA AG-3′ and reverse 5′-CTG GAA GAT GGT
GAT GGG TT-3′) was measured as the reference. The ΔΔCT
method was utilized for analysis of each sample. Results
reported as normalized to the average expression of untreated
cells.
4.10. Mitochondrial imaging
Mitochondrial morphology was visualized utilizing MitoTracker® Red CMXRos [Life Tech] according to manufacturer’s
instructions. In short, after 24 h the culture media was
removed and replaced with serum free DMEM containing a
300 nM MitoTracker® probe and incubated at 37 °C for
30 min. Cells were then washed three times with warm 1× PBS
and serum free DMEM was added for viewing with an
Olympus FV500 Inverted Confocal Microscope.
4.11. Statistical analysis
All data are presented as the mean ± standard deviation. Statistical comparisons between treatments utilized Sigma Plot
ANOVA (Dunnett’s method) for analysis. Pool sizes are as
indicated.

Acknowledgements
We thank Dr Yusong Li for access to the DLS machine. We
thank Dr You Zhou and Han Chen of the UNL Center for Biotechnology Microscopy Core Faculties for assistance in obtaining confocal and TEM images. We thank Dr Concetta Dirusso
for the use of her fluorescent plate reader. We thank

This journal is © The Royal Society of Chemistry 2015

View Article Online

Nanoscale

Dr William Velander for the use of his colorimetric spectrometer. We thank Dr Edward Harris for assistance in the glutamate uptake studies. This work was funded by NIH grants P30
GM103335 (to the Nebraska Redox Biology Center) and
1R01GM108975 (to O.K.), the start up funds from UNL’s
Layman Award, MRSEC Seed Grant and UNL Interdisciplinary
Award (to S.K.) and UNL’s Molecular Mechanisms of Diseases
Graduate Fellowship (to C.L.W.).

References
1 F. Piccinno, F. Gottschalk, S. Seeger and B. Nowack,
J. Nanopart. Res., 2012, 14, 1–11.
2 W. Thies and L. Bleiler, Alzheimer’s Dementia, 2013, 9, 208–
245.
3 A. Weir, P. Westerhoﬀ, L. Fabricius, K. Hristovski and
N. von Goetz, Environ. Sci. Technol., 2012, 46, 2242–2250.
4 I. Iavicoli, V. Leso and A. Bergamaschi, J. Nanomater., 2012,
2012, 36.
5 T. Xia, R. F. Hamilton, J. C. Bonner, E. D. Crandall,
A. Elder, F. Fazlollahi, T. A. Girtsman, K. Kim, S. Mitra,
S. A. Ntim, G. Orr, M. Tagmount, A. J. Taylor, D. Telesca,
A. Tolic, C. D. Vulpe, A. J. Walker, X. Wang,
F. A. Witzmann, N. Wu, Y. Xie, J. I. Zink, A. Nel and
A. Holian, Environ. Health Perspect., 2013, 121, 683–690.
6 J. C. Bonner, R. M. Silva, A. J. Taylor, J. M. Brown,
S. C. Hilderbrand, V. Castranova, D. Porter, A. Elder,
G. Oberdorster, J. R. Harkema, L. A. Bramble,
T. J. Kavanagh, D. Botta, A. Nel and K. E. Pinkerton,
Environ. Health Perspect., 2013, 121, 676–682.
7 J. Wang, G. Zhou, C. Chen, H. Yu, T. Wang, Y. Ma, G. Jia,
Y. Gao, B. Li and J. Sun, Toxicol. Lett., 2007, 168, 176–185.
8 J. Wang, C. Chen, Y. Liu, F. Jiao, W. Li, F. Lao, Y. Li, B. Li,
C. Ge, G. Zhou, Y. Zhao and Z. Chai, Toxicol. Lett., 2008,
183, 72–80.
9 J. Wu, J. Sun and Y. Xue, Toxicol. Lett., 2010, 199, 269–276.
10 T. C. Long, N. Saleh, R. D. Tilton, G. V. Lowry and
B. Veronesi, Environ. Sci. Technol., 2006, 40, 4346–4352.
11 P. J. Magistretti, J. Exp. Biol., 2006, 209, 2304–2311.
12 A. Panatier, D. T. Theodosis, J.-P. Mothet, B. Touquet,
L. Pollegioni, D. A. Poulain and S. H. R. Oliet, Cell, 2006,
125, 775–784.
13 V. Lebon, K. F. Petersen, G. W. Cline, J. Shen, G. F. Mason,
S. Dufour, K. L. Behar, G. I. Shulman and D. L. Rothman,
J. Neurosci., 2002, 22, 1523–1531.
14 L. Pellerin and P. J. Magistretti, Proc. Natl. Acad.
Sci. U. S. A., 1994, 91, 10625–10629.
15 A. Araque, G. Carmignoto, P. G. Haydon, S. H. R. Oliet,
R. Robitaille and A. Volterra, Neuron, 2014, 81, 728–739.
16 M. Navarrete, G. Perea, L. Maglio, J. Pastor, R. Garcia de
Sola and A. Araque, Cereb. Cortex, 2013, 23, 1240–1246.
17 A. Araque, Neuron Glia Biol., 2008, 4, 3–10.
18 A. Volterra and J. Meldolesi, Nat. Rev. Neurosci., 2005, 6,
626–640.
19 E. A. Newman, Trends Neurosci., 2003, 26, 536–542.

This journal is © The Royal Society of Chemistry 2015

Paper

20 V.
Freyre-Fonseca,
N.
L.
Delgado-Buenrostro,
E. B. Gutierrez-Cirlos, C. M. Calderon-Torres, T. CabellosAvelar, Y. Sanchez-Perez, E. Pinzon, I. Torres, E. MolinaJijon, C. Zazueta, J. Pedraza-Chaverri, C. M. Garcia-Cuellar
and Y. I. Chirino, Toxicol. Lett., 2011, 202, 111–119.
21 Y. Tang, F. Wang, C. Jin, H. Liang, X. Zhong and Y. Yang,
Environ. Toxicol. Pharmacol., 2013, 36, 66–72.
22 R. J. Youle and A. M. Van Der Bliek, Science, 2012, 337,
1062–1065.
23 D. Tondera, S. Grandemange, A. Jourdain, M. Karbowski,
Y. Mattenberger, S. Herzig, S. Da Cruz, P. Clerc, I. Raschke
and C. Merkwirth, EMBO J., 2009, 28, 1589–1600.
24 J. Yang, Q. Liu, M. Qi, S. Lu, S. Wu, Q. Xi and Y. Cai,
Environ. Toxicol., 2013, 28, 489–497.
25 A. Gramowski, J. Flossdorf, K. Bhattacharya, L. Jonas,
M. Lantow, Q. Rahman, D. Schiﬀmann, D. G. Weiss and
E. Dopp, Environ. Health Perspect., 2010, 118, 1363.
26 S. G. Márquez-Ramírez, N. L. Delgado-Buenrostro,
Y. I. Chirino, G. Gutiérrez-Iglesias and R. López-Marure,
Toxicology, 2012, 302, 146–156.
27 L. Shang, K. Nienhaus and G. U. Nienhaus, J. Nanobiotechnol., 2014, 12, 5.
28 R. Tedja, M. Lim, R. Amal and C. Marquis, ACS Nano, 2012,
6, 4083–4093.
29 T. C. Long, J. Tajuba, P. Sama, N. Saleh, C. Swartz,
J. Parker, S. Hester, G. V. Lowry and B. Veronesi, Environ.
Health Perspect., 2007, 115, 1631.
30 J. A. Kim, A. Salvati, C. Aberg and K. A. Dawson, Nanoscale,
2014, 6, 14180–14184.
31 R. Y. Prasad, K. Wallace, K. M. Daniel, A. H. Tennant,
R. M. Zucker, J. Strickland, K. Dreher, A. D. Kligerman,
C. F. Blackman and D. M. DeMarini, ACS Nano, 2013, 7,
1929–1942.
32 F. Wang, L. Yu, M. P. Monopoli, P. Sandin, E. Mahon,
A. Salvati and K. A. Dawson, Nanomedicine, 2013, 9, 1159–
1168.
33 A. Lesniak, F. Fenaroli, M. P. Monopoli, C. Aberg,
K. A. Dawson and A. Salvati, ACS Nano, 2012, 6, 5845–
5857.
34 A. Marucco, I. Fenoglio, F. Turci and B. Fubini, Journal of
Physics: Conference Series; IOP Publishing, Interaction of
fibrinogen and albumin with titanium dioxide nanoparticles
of diﬀerent crystalline phases, 2013, p. 012014.
35 Y. Li, J. Li, J. Yin, W. Li, C. Kang, Q. Huang and Q. Li,
J. Nanosci. Nanotechnol., 2010, 10, 8544–8549.
36 I. Iavicoli, Eur. Rev. Med. Pharmacol. sci., 2011, 15, 481–508.
37 S. Wang, H. Yu and J. K. Wickliﬀe, Toxicol. In Vitro, 2011,
25, 2147–2151.
38 E. Huerta-García, J. A. Pérez-Arizti, S. G. Márquez-Ramírez,
N. L. Delgado-Buenrostro, Y. I. Chirino, G. Gutiérrez-Iglesias and R. López-Marure, Free Radicals Biol. Med., 2014,
73, 84–94.
39 J. Gordon, S. Amini and M. K. White, in Neuronal Cell
Culture, Springer, 2013, pp. 1–8.
40 L. Hertz and H. R. Zielke, Trends Neurosci., 2004, 27, 735–
743.

Nanoscale, 2015, 7, 18477–18488 | 18487

View Article Online

Paper

41 N. J. Maragakis and J. D. Rothstein, Nat. Clin. Pract.
Neurol., 2006, 2, 679–689.
42 Y. Ze, R. Hu, X. Wang, X. Sang, X. Ze, B. Li, J. Su, Y. Wang,
N. Guan and X. Zhao, J. Biomed. Mater. Res. Part A, 2014,
102, 470–478.
43 A. Volterra, D. Trotti, C. Tromba, S. Floridi and G. Racagni,
J. Neurosci., 1994, 14, 2924–2932.
44 O. Sorg, T. Horn, N. Yu, D. L. Gruol and F. E. Bloom, Mol.
Med., 1997, 3, 431.
45 C. Yuan, J. Gao, J. Guo, L. Bai, C. Marshall, Z. Cai, L. Wang
and M. Xiao, PloS One, 2014, 9, e107447.
46 N. S. Chandel, BMC Biol., 2014, 12, 34.
47 J. Shin, E. Lee, S. Seo, H. Kim, J. Kang and E. Park, Neuroscience, 2010, 165, 445–454.
48 M. D. Brand and D. G. Nicholls, Biochem. J., 2011, 435,
297–312.
49 S. Hussain, K. Hess, J. Gearhart, K. Geiss and J. Schlager,
Toxicol. in Vitro, 2005, 19, 975–984.
50 K. Itoh, K. Nakamura, M. Iijima and H. Sesaki, Trends Cell
Biol., 2013, 23, 64–71.

18488 | Nanoscale, 2015, 7, 18477–18488

Nanoscale

51 J. J. Rahn, K. D. Stackley and S. S. Chan, PLoS One, 2013, 8,
e59218.
52 S. Cipolat, O. M. de Brito, B. Dal Zilio and L. Scorrano,
Proc. Natl. Acad. Sci. U. S. A., 2004, 101, 15927–15932.
53 M. J. Jou, T. I. Peng, R. J. Reiter, S. B. Jou, H. Y. Wu and
S. T. Wen, J. Pineal Res., 2004, 37, 55–70.
54 Z. E. Allouni, P. J. Høl, M. A. Cauqui, N. R. Gjerdet and
M. R. Cimpan, Toxicol. In Vitro, 2012, 26, 469–479.
55 M. Czajka, K. Sawicki, K. Sikorska, S. Popek, M. Kruszewski
and L. Kapka-Skrzypczak, Toxicol. In Vitro, 2015, 29, 1042–1052.
56 G. M. Beaudoin III, S.-H. Lee, D. Singh, Y. Yuan, Y.-G. Ng,
L. F. Reichardt and J. Arikkath, Nat. Protoc., 2012, 7, 1741–
1754.
57 S. Kidambi, I. Lee and C. Chan, Adv. Funct. Mater., 2008,
18, 294–301.
58 L. K. Braydich-Stolle, N. M. Schaeublin, R. C. Murdock,
J. Jiang, P. Biswas, J. J. Schlager and S. M. Hussain, J. Nanopart Res., 2009, 11, 1361–1374.
59 H. Chen, A. Chomyn and D. C. Chan, J. Biol. Chem., 2005,
280, 26185–26192.

This journal is © The Royal Society of Chemistry 2015

Electronic Supplementary Material (ESI) for Nanoscale.
This journal is © The Royal Society of Chemistry 2015

Mitochondrial Dysfunction and Loss of Glutamate Uptake in Primary
Astrocytes Exposed to Titanium Dioxide Nanoparticles

Christina L. Wilson1, Vaishaali Natarajan1, Stephen L. Hayward1, Oleh Khalimonchuk2,
and Srivatsan Kidambi1,3,4,*
1Department

of Chemical and Biomolecular Engineering,

University of Nebraska-Lincoln, NE, 68588
2Department

of Biochemistry and Nebraska Redox Biology Center,

University of Nebraska-Lincoln, NE, 68588
3Nebraska

Center for Materials and Nanoscience,

University of Nebraska-Lincoln, NE, 68588
4Regenerative

Medicine Program,

University of Nebraska Medical Center, NE, 68198.

*indicates

corresponding author. Email: skidambi2@unl.edu

SUPPLEMENTARY INFORMATION

Suppl Fig 1. Lethal Concentration. Lethal concentration was quantified at 0ppm,
25ppm, 50ppm, 100ppm, 300ppm, 500ppm, 700ppm and 1000ppm nanoparticle. P25
(A) was observed to be the most lethal nanoparticle after 24 hr treatment followed by
anatase (B) and rutile (C) as determined by calculating the LC50 utilizing sigma plot
analysis. (N = 6).

Suppl Fig 2. Acellular stained images of TiO2 nanoparticles with MitoTracker Red.
Confocal phase (A-D) and florescent (E-H) images of no nanoparticles (A,E), 100 ppm
P25 (B,F), 100 ppm Anatase (C, G) and 100 ppm Rutile (D,H) nanoparticles treated with
300 nM MitoTrackerR Red CMXROS dye as described in the experimental section.
Scale bar 10 µm.

Suppl Fig 3. Representative images of the untreated astrocyte culture. The astrocyte
culture utilized for experiments was characterized by immunostaining with anti-glial
fibrillary acidic protein (GFAP, red) and DAPI nuclear staining (blue). Cells were fixed
with 4% paraformaldehyde for 20 min, permeabilized in 0.1% Triton X-100 for 15 min
and background blocked with 1% bovine serum albumin (BSA) in PBS for 1 hr at room
temperature. Cells were stained in primary antibody solution (1:1000 anti-GFAP [DAKO]
in 1% BSA in PBS) at 4 °C overnight, secondary antibody solution (1:500 anti-Rabbit
rhodamine [Millipore] in PBS) for 2 hr at room temperature and DAPI staining solution (1
µg/ml DAPI in PBS) for 5 min at room temperature. Images were obtained using
Axiovert 40 CFL [Zeiss] and images taken with a Progres C3 [Jenoptick] camera with an
X-Cite series 120Q [Lumen Dynamics] lamp and a CY3 or DAPI filter [Chroma]. Culture
purity was determined to be > 90 % astrocytes by counting the number of GFAP
positive nuclei over the total nuclei using Image J cell counter [NIH.gov].

